Follitropin Alfa

DRUG14 trials

Sponsors

Assistance Publique Hopitaux De Paris, Centre Oscar Lambret, Amsterdam UMC Stichting, Ferring Pharmaceuticals, Finox AG

Conditions

Controlled Ovarian SimulationFemale InfertilityFertility DisordersFertility IssuesGynecologic DiseaseIVFIVF (In vitro fertilization) or ICSI (intracytoplasmic sperm injection) protocol with embryo transfer planned on the same cycle.Infertility

Phase 2

Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®

CompletedNCT01794208

Glycotope GmbHInfertility

Start: 2013-01-08End: 2013-07-30Updated: 2021-05-07

CHACRY-1501 : RISK OF INFERTILITY RELATED TO ADJUVANT CHEMOTHERAPY IN YOUNG BREAST CANCER PATIENTS: OOCYTE/EMBRYO CRYOPRESERVATION

Active, not recruitingCTIS2024-513078-23-00

Centre Oscar Lambretbreast cancer in young women

Start: 2016-12-02Target: 139Updated: 2025-01-31

Phase 3

Multi-centre Study to Compare Efficacy and Safety of AFOLIA and Gonal-f in Women for Assisted Reproductive Treatment

CompletedNCT01121666

Finox AGInfertility

Start: 2010-06-30End: 2013-03-31Updated: 2016-04-15

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

CompletedNCT03296527

Ferring PharmaceuticalsControlled Ovarian Simulation

Start: 2017-12-01End: 2020-07-26Updated: 2023-08-24

SOLOAGO - Luteal phase support by GnRH agonist alone after GnRH agonist triggering compared to the reference protocol (hCG triggering and luteal support with progesterone) in IVF: a randomized controlled trial.

RecruitingCTIS2023-505126-34-00

Assistance Publique Hopitaux De ParisIVF (In vitro fertilization) or ICSI (intracytoplasmic sperm injection) protocol with embryo transfer planned on the same cycle.

Start: 2024-06-27Target: 652Updated: 2025-05-21

Phase 4

A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa

CompletedNCT00257556

Ferring PharmaceuticalsInfertility

Start: 2005-10-31End: 2009-04-30Updated: 2010-02-26

Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI

MinaPharm PharmaceuticalsFemale Infertility

Start: 2017-02-09End: 2018-01-31Target: 200Updated: 2017-08-30

Estradiol and Progesterone Levels Following Frozen Embryo Transfer

CompletedNCT04997525

Copenhagen University Hospital at HerlevInfertility

Start: 2021-04-20End: 2024-12-06Updated: 2025-01-03

Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders

WithdrawnNCT05405686

CRG UZ BrusselPoor Response to Ovulation Induction

Start: 2023-05-01End: 2024-08-01Updated: 2024-02-28

Continuous Double Ovarian Stimulation.

CompletedNCT05815719

Instituto BernabeuFertility Issues

Start: 2022-11-17End: 2023-05-30Updated: 2025-05-18

Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome

RecruitingCTIS2024-519354-36-00

Amsterdam UMC StichtingPolycystic ovary syndrome (PCOS)

Start: 2025-08-01Target: 816Updated: 2025-05-30

Unknown Phase

An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data

CompletedNCT04854707

IVFarma LLCFertility Disorders, Fertility Issues, Gynecologic Disease +3

Start: 2020-01-12End: 2021-01-20Updated: 2021-10-22

Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders

CompletedNCT05103228

Peter Kovacs MDInfertility, Ovarian Dysfunction

Start: 2021-12-02End: 2023-07-20Updated: 2024-12-13

Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

RecruitingNCT06481696

Andros Day Surgery ClinicUnexplained Infertility

Start: 2024-06-01End: 2025-12-31Target: 90Updated: 2024-07-01

Related Papers

Cost-Effectiveness of Follitropin Delta Compared with Follitropins Alfa and Beta in Controlled Ovarian Stimulation for Assisted Reproductive Technologies (ART) in France.

2026-03-11

P-581 Optimizing efficiency and enhancing patient convenience in DuoStim cycles: A study exploring the continuous application of corifollitropin alpha

Human Reproduction2024-07-01

O-013 Population pharmacokinetics of follitropin delta during ovarian stimulation

Human Reproduction2024-07-01

P-655 Live birth rate in the fresh cycle associated with number of oocytes in ovarian stimulation with individualised follitropin delta: an individual patient data meta-analysis

Human Reproduction2024-07-01

Continuous ovarian stimulation: a proof-of-concept study exploring the uninterrupted use of corifollitropin α in DuoStim cycles for enhanced efficiency and patient convenience (Alicante protocol).

2024-03-282 citations

Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization /intracytoplasmic sperm injection

Reproductive Biology and Endocrinology2022-10-0414 citations

Estradiol and progesterone levels in early pregnancy after natural, estradiol + progesterone or gonadotrophin stimulated frozen embryo transfer cycle: a randomised controlled trial protocol

BMJ Open2022-07-014 citations

O-114 Improved safety and efficiency of individualised versus conventional gonadotropin dosing for ovarian stimulation in IVF/ICSI: an individual patient meta-analysis (IPD-MA)

Human Reproduction2021-07-013 citations

P–650 Body weight is the main determinant of systemic follicle stimulating hormone (FSH) concentrations during controlled ovarian stimulation with follitropin delta

Human Reproduction2021-07-013 citations

O-110 A randomised, controlled, assessor-blind trial assessing clinical outcomes of individualised dosing with follitropin delta in Asian IVF/ICSI patients

Human Reproduction2021-07-01

A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients

Human Reproduction2021-06-0365 citations